N-7-Hydroxymethyl Baricitinib is supplied with detailed characterization data compliant with regulatory guideline. N-7-Hydroxymethyl Baricitinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ruxolitinib.